Policy / Pricing Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director BioPharma DiveIf confirmed by the Senate, Schwartz could finally fill a void for an agency that s cycled through multiple leaders over the last year.Policy / PricingRead full story pharminent April 16, 2026 (Last updated: April 17, 2026) BioPharma Dive If confirmed by the Senate, Schwartz could finally fill a void for an agency that s cycled through multiple leaders over the last year. Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: FDA moves toward easing restrictions on certain peptidesNext: Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
